Antiviral therapy in hepatitis B virus-infected immunotolerant children, exploring a new land

I have read with great interest the article presented by Zhu et al. titled “Antiviral therapy in hepatitis B virus-infected children with immune-tolerant characteristics: A pilot open-label randomized study” published in Journal of Hepatology in June 2018. 1 The study explores an important area of HBV yet to be fully explored, and has stretched restrictive boundaries p roposed by treatment guidelines, as the American Association for the Study of Liver Diseases suggested antiviral therapy in HBV e antigen positive children (ages 2 to
Source: Journal of Hepatology - Category: Gastroenterology Authors: Tags: Letter to the Editor Source Type: research